ASHLEY DOMZALSKI: Open Payments
NPI 1093226557 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 46 payments from 21 companies in 2025. Trend: 2023 $3,762 · 2024 $1,638 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC | 6 | $121 |
| ABBVIE INC. | 5 | $116 |
| PFIZER INC. | 4 | $99 |
| Merz Pharmaceuticals, LLC | 4 | $99 |
| ACADIA Pharmaceuticals Inc | 4 | $90 |
| Alexion Pharmaceuticals, Inc. | 3 | $60 |
| ARGENX US, INC. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Eisai Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
Products named: ONGENTYS, BOTOX, NUPLAZID, INBRIJA, ULTOMIRIS, NURTEC ODT, VYVGART HYTRULO, WAINUA.
Industry payments across PA — which companies pay providers there.
